IPO Boutique Research, Color & More Information for Subscribers
Week of Feb. 2nd Eyegate Pharmaceuticals (Nasdaq: EYEG) Wednesday AltheaDx, Inc (Nasdaq: IDGX) Infraredx (Nasdaq: REDX) Carbylan Therapeutics (Nasdaq: CBYL) Thursday Asante Solutions, Inc. (Nasdaq: PUMP) Inotek Pharmaceuticals Corporation (Nasdaq: ITEK) Nexvet Biopharma plc (Nasdaq: NVET) Advanced Accelerator Applications S.A. (Nasdaq: AAAP) Friday Check-Cap Ltd (Nasdaq: CHEK) Columbia Pipeline Partners LP (NYSE: CPPL) Easterly Government[…]
This past week ten IPOs debuted, six updated terms and zero new deals filed. Of the ten deals that came to market, two of them—Shake Shack (NYSE: SHAK) and Spark Therapeutics (Nasdaq: ONCE)—closed their opening day with more than a 100% premium above their respective offering prices. It was the first time two IPOs
Shake Shack (NYSE: SHAK) — Shake Shack prices deal above range. Shake Shack prices 5 million shares at $21 and will debut on Friday. Spark Therapeutics (Nasdaq: ONCE) — Spark Therapeutics upsizes IPO and prices above range. Spark prices 7 million shares at $23.00 and will debut on Friday. The revised range was 6.5 million[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here. Company: K2M Group Holdings
Friday’s IPO–Shake Shack (NYSE: SHAK)–will likely be the deal of the week. We were quoted in an Investors.Com article about why the deal is so hot. “It’s a fast-growth story,” said Jeff Zell, research analyst at IPOboutique. “Almost all of the fast-casual restaurant deals in the past year have all popped above their offering price.”[…]
Flex Pharma (Nasdaq: FLKS) – Flex Pharma upsizes and prices deal above range. Flex prices 5.4 million shares at $16.00. The initial filing stated that they would offer 4.6 million shares at a range of $12-$14. Entellus Medical (Nasdaq: ENTL) – Entellus Medical upsizes IPO and prices at top end of range. The deal was[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here. Company: Omeros
It appears that a pair of company’s who are IPO’ing this week are looking to take advantage of demand. Shake Shack (NYSE: SHAK) has increased the range from $14-$16 to $17-$19–representing a 20% increase if priced at the mid-point. Additionally, one of nine healthcare sector deals has not only increased its range, but its size[…]
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here. Company: Synergy Resources
Last week, CNBC’s popular hosts gave a raving review about Box’s upcoming IPO. The deal opened 44% higher and traded as high as 77% above the IPO price. This week, Cramer is on the prowl for another IPO: Shake Shack (NYSE: SHAK)
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here. Company: Post Holding
Tuesday Zosano Pharma (Nasdaq: ZSAN) Wednesday Presbia PLC (Nasdaq: LENS) Thursday Ascendis Pharma A/S (Nasdaq: ASND) Entellus Medical (Nasdaq: ENTL) Flex Pharma (Nasdaq: FLKS) Friday Avinger (Nasdaq: AVGR) Infraredx (Nasdaq: REDX) InfraREIT (NYSE: HIFR) Shake Shack (NYSE: SHAK) Spark Therapeutics (Nasdaq: ONCE) Tracon Pharmaceuticals (Nasdaq: TCON) Subscribe now to get our full research report, IPO[…]
This past week one IPO debuted, twelve updated terms and one new deal filed. A highly anticipated deal, Box Inc. (NYSE: BOX), came to market on Friday after pricing $1 above the range ($14). ‘BOX’ opened 44% higher with a $20.20 print at first trade. Box fared even better in the aftermarket as the deal[…]
Last night, Box, Inc. (NYSE: BOX) priced its IPO $1 above the $11-$13 range at $14. The deal was 12.5 million shares and raised $175 million for the company. Box was the subject of a lot of media speculation this week. Box was valued at $2.4 billion during its last round of funding yet is[…]
According to the lead underwriter, Box, Inc. (NYSE: BOX) has priced 12.5 million shares at $14 and will debut on Friday (1/23). The initial range for the IPO as provided by the prospectus was $11-$13.
Fortune quotes a partner at venture capitalist Benchmark, Bill Gurley, in their February cover story: “I think you’re going to see a lot of failure in 2015.” The idea that tech start-ups can have a $1b valuation relatively easy is head scratching to some money-managers. The downfalls of repeated rounds of funding is laid out[…]
Company: Radius Health, Inc. Symbol: RDUS Price: Last trade $39.37 Trade Date: 1/23 Shares: 3.5 million Underwriter(s) Goldman Sachs, BofA Merrill Lynch, Cowen & Co. Rating=Subscribe for Rating Company: Zafgen, Inc. Symbol: ZFGN Price: Last trade $34.79 Trade Date: 1/22 Shares: 2.84 million Underwriter(s) Leerink Partners, Cowen & Co. Co Manager(s) Canaccord Genuity, JMP Securities[…]
There is just one IPO on the schedule this week, Box, Inc. (NYSE: BOX) and it has at least one endorsement—one from CNBC’s Mad Money host Jim Cramer. “I bet a big thaw could be coming later this week in the form of a new offering that could get people very excited about IPOs again,”[…]
IPOBoutique is a full service syndicate boutique. We not only relay color and advisories on IPOs, but we rate every secondary that hits the tape on a nightly basis. We also provide a track record for secondary’s we have issued a ‘BUY’ rating to. Company: Alnylam
We expected 2015 to be a robust year for IPOs and were somewhat surprised that more deals did not come to market or set terms before MLK Day. However, that surprise was greeted with eight companies releasing official filings to the SEC setting terms for their respective IPOs. Avinger (Nasdaq: AVGR) – Trade Date: Week[…]